Cargando…

Guillain–Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea

Detalles Bibliográficos
Autores principales:	Kim, Namkyun, Kim, Jae-Hyung, Park, Jin-Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723705/ https://www.ncbi.nlm.nih.gov/pubmed/34981285 http://dx.doi.org/10.1007/s10072-021-05849-0

Ejemplares similares

Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus
por: Kang, Minsung, et al.
Publicado: (2023)

Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
por: Fotiadou, Aggeliki, et al.
Publicado: (2022)

Guillain-Barré syndrome associated with COVID-19: an atypical, late-onset presentation
por: Fletman, Elizabeth W., et al.
Publicado: (2021)

Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
por: Sauerwein, Kai M.T., et al.
Publicado: (2023)

HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
por: Gigli, Gian Luigi, et al.
Publicado: (2020)

COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
por: Martinelli-Boneschi, Filippo, et al.
Publicado: (2022)

First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
por: Umezawa, Shu, et al.
Publicado: (2022)

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
por: Kang, Yu Min, et al.
Publicado: (2021)

Effect of COVID-19 vaccination on transmission among healthcare workers in South Korea
por: Kim, Jiyun, et al.
Publicado: (2022)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital
por: Ottaviani, Donatella, et al.
Publicado: (2020)

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications
por: Kajumba, Mayanja M., et al.
Publicado: (2020)

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
por: Kerr, Steven, et al.
Publicado: (2022)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine()
por: Sosa-Hernández, Oscar, et al.
Publicado: (2022)

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022)

Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine
por: García-Grimshaw, Miguel, et al.
Publicado: (2021)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in Korea
por: Hwang, Myung-Jae, et al.
Publicado: (2022)

Epidemiological characteristics of and containment measures for COVID-19 in Busan, Korea
por: Son, Hyunjin, et al.
Publicado: (2020)

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?
por: Haji, Alhan, et al.
Publicado: (2023)

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey
por: Noh, Yunha, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea
por: Yoon, Kyuhyun, et al.
Publicado: (2022)

Inequitable distribution of excess mortality during the COVID-19 pandemic in Korea, 2020
por: Kim, Jin-Hwan, et al.
Publicado: (2022)

Cause-specific mortality in Korea during the first year of the COVID-19 pandemic
por: Bahk, Jinwook, et al.
Publicado: (2022)

Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
por: Kim, Soyeoun, et al.
Publicado: (2022)

Time-variant reproductive number of COVID-19 in Seoul, Korea
por: Moon, Seong-Geun, et al.
Publicado: (2020)

Herd immunity: challenges and the way forward in Korea
por: Oh, Jiyoung, et al.
Publicado: (2021)

Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea
por: Park, Yong-Shik, et al.
Publicado: (2017)

Effect of socioeconomic disparities on the risk of COVID-19 in 8 metropolitan cities in the Korea: a community-based study
por: Hwang, Myung-Jae, et al.
Publicado: (2022)

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa
por: Iannone, Michela, et al.
Publicado: (2021)

Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment
por: Min, Kyung-Duk, et al.
Publicado: (2021)

Analysis of the on-ship transmission of the COVID-19 mass outbreak on the Republic of Korea Navy amphibious warfare ship
por: Cho, Soo Hyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj8m2niah8kkheunfojddot5ne